Important: New Login Process
We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.
- If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
- If you log in with a username and password, you will be prompted to set a new password before accessing your account.
Go to the Login Page to get started.
We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.
- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a company name.
Oncosec Medical Inc.
Headquarters: San Diego, CA, United States of America
Website: N/A
Year Founded: 2011
Status: Out of Business
BioCentury | Feb 14, 2023
Data Byte
The IL-12 clinical pipeline: about as many modalities as molecules
The companies casting wide net in attempt to harness IL-12’s immune stimulation without its toxicity
BioCentury | Nov 2, 2022
Management Tracks
Cox to head digital health at Pfizer
Plus Stegmeier joins Curie Bio and updates from Actinium, Lexeo and more
BioCentury | Oct 6, 2022
Management Tracks
J&J’s Kumar becomes Cure’s CEO
Plus Shanton recruits LianBio’s Li and updates from BlueSphere, Valence and Apnimed
BioCentury | Jan 27, 2022
Data Byte
Plasmid-based gene therapies – a small but growing pipeline
An old method makes a comeback
BioCentury | Oct 26, 2021
Management Tracks
Biden picks tech lawyer Vidal to head USPTO
Zaks joins Deep Genomics’ board, plus Akoya, Avrobio, Immunicum and more
BioCentury | Oct 6, 2021
Management Tracks
Weinstein becomes CFO at Caris Life Sciences
Plus: Kezar, PDS, aTyr, Rosewell, Orum and more
BioCentury | Jun 24, 2021
Management Tracks
OncoSec, Adverum report C-suite resignations; plus CytoImmune, Intellia, Twelve Bio, IgGenix and more
BioCentury | Feb 4, 2021
Management Tracks
Novo Foundation names Krogsgaard Thomsen CEO; plus Takeda’s Sequeira to become first woman to chair PhRMA and updates from Almirall, Twist, Oncosec and more
Biomedical research foundation Novo Nordisk Foundation named Mads Krogsgaard Thomsen, EVP and CSO at Novo Nordisk A/S (CSE:NOVO B; NYSE:NVO) as CEO, effective March 1. He replaces Birgitte
BioCentury | Nov 11, 2020
Product Development
Nov. 10 Quick Takes: Tezepelumab meets in asthma Phase III; plus a call for speedy trial results, updates on COVID vaccines from Sinovac, CureVac and more
AZ, Amgen rise on asthma dataTezepelumab from AstraZeneca plc (LSE:AZN; NYSE:AZN) and Amgen Inc. (NASDAQ:AMGN) met the primary endpoint of a statistically significant reduction in annualized asthma
BioCentury | Oct 12, 2020
Management Tracks
Rivera joins Akili as CMO; plus moves at Polyneuron, Checkmate, CytomX, BIO, ProQR, Silence and OncoSec
Meghan Rivera joined Akili Interactive Labs Inc. as CMO to lead marketing and sales of EndeavorRx, a digital treatment for children with ADHD, which was cleared by the FDA in June. Rivera
Items per page:
1 - 10 of 78